News

Medigene submits CTA for its first clinical trial with proprietary TCR cellular immunotherapy MDG1011

SHOW RELEASE

Medigene announces participation at further national and international conferences

SHOW RELEASE

Medigene and academic partners publish a method to enhance adoptive T-cell therapies

SHOW RELEASE

Reports outcome of Annual General Meeting and announces new Supervisory Board Members

SHOW RELEASE

Medigene reports results of first quarter 2017

SHOW RELEASE

Dave Lemus steps down as COO and continues cooperation in an advisory role

SHOW RELEASE

Medigene successfully raises EUR 20.7 million in oversubscribed private placement

SHOW RELEASE

Medigene announces capital increase of new shares

SHOW RELEASE

Medigene announces participation at six international conferences

SHOW RELEASE

Medigene presented preclinical data on its PRAME-specific TCR at AACR conference

SHOW RELEASE